Eva Catalá is a Global Development Medical Director at AstraZeneca, having started in 2025. Previously, they served as an attending physician and hematologist at Hospital Gregorio Marañón from 2022 to 2024, and completed a hematology fellowship at Vall d'Hebron Barcelona Hospital Campus from 2018 to 2022. Eva also held a position as a Clinical Research Fellow in the Immune Effector Cell Program at Dana-Farber Cancer Institute from 2024 to 2025. They obtained a degree in medicine from Universitat Jaume I, graduating in 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices